PetCaseFinder

Peer-reviewed veterinary case report

MicroRNA differences in free and vesicle blood samples in dogs

By Capuano, Cecilia et al.·Published in Frontiers in veterinary science·2024·Anicura Istituto Veterinario di Novara, Italy·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Free circulating versus extracellular vesicle-associated microRNA expression in canine T-cell lymphoma.

Species:
dog
LymphomaBehaviour & energyDogs

Plain-English summary

A group of eight dogs with T-cell lymphoma, a serious type of cancer, was studied to see if certain tiny molecules called microRNAs could help in diagnosing the disease. Researchers compared these dogs to eight healthy dogs and found that some microRNAs were present in higher amounts in the dogs with lymphoma. One specific microRNA, has-miR-222-3p, was found to be elevated in both groups. This suggests that these microRNAs, especially those associated with tiny particles called extracellular vesicles, could be useful in future tests for diagnosing T-cell lymphoma in dogs.

People also search for: dog lymphoma symptoms · T-cell lymphoma treatment in dogs · microRNA in canine cancer

Abstract

INTRODUCTION: Canine lymphoma (cL) is one of the most frequent cancers in dogs. The T-cell lymphoma (TcL) is not the most common phenotype but presents an aggressive behavior. MicroRNAs (miRNAs), are small, single-stranded, non-coding RNA molecules which can circulate freely in blood or be associated with extracellular vesicles (EVs). The dysregulation of certain miRNAs has been identified in numerous types of human cancers and they have been largely investigated as possible tumors biomarkers in human medicine, while research in veterinary oncology is still scarce. The aim of this study was to compare the expression patterns of free circulating and EV-associated miRNAs in dogs with T-cell lymhoma (TcL) and healthy dogs. METHODS: Eight dogs with TcL were selected as the lymphoma group (LG) and eight dogs were included as controls (Ctrl). Plasma samples were collected at the time of the diagnosis and EVs isolated with ultracentrifugation. miRNAs were extracted from both the circulating EVs and the plasma supernatant, obtaining EV-associated and free-miRNAs. Quantitative real-time PCR was performed to analyze the expression of 88 target miRNAs. RESULTS: Ten and seven differentially expressed miRNAs between LG and Ctrl were detected in EV-associated and free-miRNAs, respectively. Among EV-associated and free-miRNAs, only has-miR-222-3p was overexpressed in both conditions. DISCUSSION: All the differentially expressed miRNAs detected in this study, have been already described as dysregulated in other human or canine cancers. The EV-associated miRNAs, which appear to be more stable and better conserved than free-miRNAs, could be investigated in further larger studies to better assess their use as possible biomarkers for TcL.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/39268522/